Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2017, Article ID 9536025, 6 pages
https://doi.org/10.1155/2017/9536025
Research Article

Treatment Gaps Found in the Management of Type 2 Diabetes at a Community Health Centre in Johannesburg, South Africa

1Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
2Division of Epidemiology and Biostatistics, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
3Carbohydrate and Lipid Metabolism Research Unit, Division of Endocrinology and Metabolism, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

Correspondence should be addressed to Yacob Pinchevsky; moc.liamg@yksvehcnipj

Received 17 March 2017; Revised 18 August 2017; Accepted 12 September 2017; Published 10 October 2017

Academic Editor: Fabrizio Barbetti

Copyright © 2017 Yacob Pinchevsky et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. International Diabetes Federation, “IDF Diabetes Atlas,” 7th edition, 2015, http://www.diabetesatlas.org. (updated 8 September 2016).
  2. World Health Organization, “The top 10 causes of death fact sheet no 310,” 2014, http://www.who.int/mediacentre/factsheets/fs310/en/ (updated 8 September 2016).
  3. The UK Prospective Diabetes Study (UKPDS) Group, “Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33),” Lancet, vol. 352, pp. 837–853, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. R. R. Holman, S. K. Paul, M. A. Bethel, D. R. Matthews, and H. A. Neil, “10-year follow-up of intensive glucose control in type 2 diabetes,” The New England Journal of Medicine, vol. 359, pp. 1577–1589, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. “The 2012 SEMDSA guideline for the management of type 2 diabetes,” Journal of Endocrinology, Metabolism and Diabetes of South Africa, vol. 17, no. 1, pp. S1–S95, 2012, http://www.semdsa.org.za/images/2012_SEMDSA_Guideline_July_FINAL.pdf (updated 8 September 2016).
  6. A. J. Ahmann, “Guidelines and performance measures for diabetes,” The American Journal of Managed Care, vol. 13, Supplement 2, pp. S41–S46, 2007. View at Google Scholar
  7. “The Wits Reproductive Health and HIV Institute (Wits RHI), Hillbrow Health Precinct,” http://www.wrhi.ac.za/about/hillbrow-health-precinct (updated 8 September 2016).
  8. Y. K. Seedat, M. A. Croasdale, F. J. Milne et al., “South African Hypertension Guideline 2006,” South African Medical Journal, vol. 96, pp. 337–362, 2006. View at Google Scholar
  9. Y. Pinchevsky, N. Butkow, F. Raal, and T. Chirwa, “The implementation of guidelines in a South African population with type 2 diabetes,” Journal of Endocrinology, Metabolism and Diabetes of South Africa, vol. 18, pp. 154–158, 2013. View at Publisher · View at Google Scholar
  10. S. Pillay, C. Aldous, and F. Mahomed, “Diabetic patients served at a regional level hospital: what is their clinical picture?” Journal of Endocrinology, Metabolism and Diabetes of South Africa, vol. 20, no. 1, pp. 50–56, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. R. J. Mash, H. Rhode, M. Zwarenstein et al., “Effectiveness of a group diabetes education programme in under-served communities in South Africa: a pragmatic cluster randomized controlled trial,” Diabetic Medicine, vol. 31, no. 8, pp. 987–993, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. A. M. Klisiewicz and F. J. Raal, “Sub-optimal management of Type 2 diabetes mellitus—a local audit,” Journal of Endocrinology, Metabolism and Diabetes of South Africa, vol. 1, no. 14, pp. 13–16, 2009. View at Publisher · View at Google Scholar
  13. E. M. Webb, P. Rheeder, and D. G. Van Zyl, “Diabetes care and complications in primary care in the Tshwane district of South Africa,” Primary Care Diabetes, vol. 9, no. 2, pp. 147–154, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. M. A. Stone, G. Charpentier, K. Doggen et al., “Quality of care of people with type 2 diabetes in eight European countries: findings from the Guideline Adherence to Enhance Care (GUIDANCE) study,” Diabetes Care, vol. 36, no. 9, pp. 2628–2638, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Stark Casagrande, J. E. Fradkin, S. H. Saydah, K. F. Rust, and C. C. Cowie, “The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988–2010,” Diabetes Care, vol. 36, no. 8, pp. 2271–2279, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. R. C. Turner, C. A. Cull, V. Frighi, and R. R. Holman, “Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group,” The Journal of the American Medical Association, vol. 281, pp. 2005–2012, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. S. T. Ntuli, E. Maimela, M. Alberts, S. Choma, and S. Dikotope, “Prevalence and associated risk factors of hypertension amongst adults in a rural community of Limpopo Province, South Africa,” African Journal of Primary Health Care & Family Medicine, vol. 7, no. 1, p. 847, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Lloyd-Sherlock, J. Beard, N. Minicuc, S. Ebrahim, and S. Chatterji, “Hypertension among older adults in low- and middle-income countries: prevalence, awareness and control,” International Journal of Epidemiology, vol. 43, no. 1, pp. 116–128, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. UK Prospective Diabetes Study Group, “Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38,” British Medical Journal, vol. 317, pp. 703–713, 1998. View at Publisher · View at Google Scholar
  20. G. L. Bakris, “A practical approach to achieving recommended blood pressure goals in diabetic patients,” Archives of Internal Medicine, vol. 161, pp. 2661–2667, 2001. View at Publisher · View at Google Scholar
  21. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia), “Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy,” Lancet, vol. 349, no. 9069, pp. 1857–1863, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. M. R. DiMatteo, P. J. Giordani, H. S. Lepper, and T. W. Croghan, “Patient adherence and medical treatment outcomes: a meta-analysis,” Medical Care, vol. 40, pp. 794–811, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Krousel-Wood, S. Thomas, P. Muntner, and D. Morisky, “Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients,” Current Opinion in Cardiology, vol. 19, pp. 357–362, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. L. A. Leiter, D. J. Betteridge, A. R. Chacra et al., “AUDIT study. Evidence of global undertreatment of dyslipidaemia in patients with type 2 diabetes mellitus,” The British Journal of Diabetes & Vascular Disease, vol. 6, pp. 31–40, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. Y. Pinchevsky, V. Shukla, N. Butkow, F. Raal, and T. Chirwa, “The achievement of glycaemic, blood pressure and LDL cholesterol targets in patients with type 2 diabetes attending a South African tertiary hospital outpatient clinic,” Journal of Endocrinology, Metabolism and Diabetes of South Africa, vol. 20, pp. 81–86, 2015. View at Publisher · View at Google Scholar · View at Scopus
  26. S. A. Hayat, B. Patel, R. S. Khattar, and R. A. Malik, “Diabetic cardiomyopathy: mechanisms, diagnosis and treatment,” Clinical Science, vol. 107, no. 6, pp. 539–557, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Gaede, P. Vedel, N. Larsen, G. V. Jensen, H. H. Parving, and O. Pedersen, “Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes,” The New England Journal of Medicine, vol. 348, pp. 383–393, 2003. View at Publisher · View at Google Scholar · View at Scopus